Invesco NASDAQ Biotechnology ETF
IBBQ
15 hedge funds and large institutions have $9.26M invested in Invesco NASDAQ Biotechnology ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
3.35% less ownership
Funds ownership: 37.02% → 33.68% (-3.3%)
12% less funds holding
Funds holding: 17 → 15 (-2)
15% less capital invested
Capital invested by funds: $10.9M → $9.26M (-$1.65M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFC
Strategic Financial Concepts
San Antonio,
Texas
|
+$1.94M |
| 2 |
PCIG
Partners Capital Investment Group
Boston,
Massachusetts
|
+$282K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$276K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$189K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$96.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSAG
Lake Street Advisors Group
Portsmouth,
New Hampshire
|
-$286K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$22.4K |
| 3 |
Morgan Stanley
New York
|
-$10.9K |
IBBQ Hedge Fund Activity: Q2 2024 in Review
15 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q2 2024, worth a combined $9.26M — down 15% from $10.9M a quarter earlier.
Fund positioning in IBBQ was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 6 added to existing stakes and 2 trimmed.
The largest buyer was Strategic Financial Concepts, opening a new position worth an estimated $1.94M. The largest seller was Lake Street Advisors Group, exiting entirely with an estimated $286K sold.
- 15 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q2 2024, down from 17 in Q1 2024.
- Funds reported $9.26M of Invesco NASDAQ Biotechnology ETF stock for Q2 2024, down 15% quarter-over-quarter.
- 1 fund opened new Invesco NASDAQ Biotechnology ETF positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q2 2024 was Strategic Financial Concepts, an estimated $1.94M added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q2 2024 was Lake Street Advisors Group, an estimated $286K sold.
Based on aggregated 13F filings for Q2 2024.